Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless...
Publications
2 shownCardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 8,612
- Institution
- Boehringer Ingelheim (Taiwan)
External Links
Identifiers
- ORCID
- 0000-0001-9133-8450
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.